Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix

ClinicalTrials.gov ID: NCT00006224

Public ClinicalTrials.gov record NCT00006224. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of Gemcitabine in Persistent or Recurrent Non-Squamous Cell Carcinoma of the Cervix

Study identification

NCT ID
NCT00006224
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
Not listed

Conditions and interventions

Interventions

  • gemcitabine hydrochloride Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2000
Primary completion
Mar 31, 2005
Completion
Not listed
Last update posted
Apr 10, 2013

Started 2000

United States locations

U.S. sites
38
U.S. states
24
U.S. cities
34
Facility City State ZIP Site status
University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama 35294-3300
Jonsson Comprehensive Cancer Center, UCLA Los Angeles California 90095-1781
Community Hospital of Los Gatos Los Gatos California 95032
Chao Family Comprehensive Cancer Center Orange California 92868
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307-5000
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612-9497
Rush-Presbyterian-St. Luke's Medical Center Chicago Illinois 60612
University of Chicago Cancer Research Center Chicago Illinois 60637-1470
Indiana University Cancer Center Indianapolis Indiana 46202-5289
Holden Comprehensive Cancer Center at The University of Iowa Iowa City Iowa 52242-1009
Albert B. Chandler Medical Center, University of Kentucky Lexington Kentucky 40536-0084
Tufts University School of Medicine Boston Massachusetts 02111
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201-1379
University of Mississippi Medical Center Jackson Mississippi 39216-4505
Ellis Fischel Cancer Center - Columbia Columbia Missouri 65203
Ellis Fischel Cancer Center Columbia Missouri 65203
Washington University School of Medicine St Louis Missouri 63110
Cooper Hospital/University Medical Center Camden New Jersey 08103
Cancer Center of Albany Medical Center Albany New York 12208
State University of New York Health Science Center at Brooklyn Brooklyn New York 11203
Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina 27599-7295
Duke Comprehensive Cancer Center Durham North Carolina 27710
Comprehensive Cancer Center at Wake Forest University Winston-Salem North Carolina 27157-1082
Barrett Cancer Center, The University Hospital Cincinnati Ohio 45267-0502
Ireland Cancer Center Cleveland Ohio 44106-5065
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195
Arthur G. James Cancer Hospital - Ohio State University Columbus Ohio 43210-1240
University of Oklahoma College of Medicine Oklahoma City Oklahoma 73190
Abington Memorial Hospital Abington Pennsylvania 19001
Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850
University of Pennsylvania Cancer Center Philadelphia Pennsylvania 19104-4283
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Medical University of South Carolina Charleston South Carolina 29425-0721
Brookview Research, Inc. Nashville Tennessee 37203
Simmons Cancer Center - Dallas Dallas Texas 75235-9154
Fletcher Allen Health Care - Medical Center Campus Burlington Vermont 05401
Cancer Center at the University of Virginia Charlottesville Virginia 22908
Tacoma General Hospital Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00006224, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 10, 2013 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00006224 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →